Advertisement

Topics

Kolon TissueGene To Start US Phase III Clinical Trial For Invossa

21:07 EDT 5 Jul 2018 | Drugs.com

ROCKVILLE, Md., July 6, 2018 /PRNewswire/ -- Kolon TissueGene, Inc. ("the Company"), a leader in advanced cell and gene therapies, announced today that Clinical Hold issued by the FDA has been lifted effective July 5, 2018 and that the Company now...

Original Article: Kolon TissueGene To Start US Phase III Clinical Trial For Invossa

NEXT ARTICLE

More From BioPortfolio on "Kolon TissueGene To Start US Phase III Clinical Trial For Invossa"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...